GE HealthCare announced the launch of Caption AI artificial intelligence-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. Now, with Caption AI technology, clinicians using Vscan Air SL handheld ultrasound will have access to real-time, step-by-step guidance to capture diagnostic-quality images and automated ejection fraction estimation to help inform clinical decisions across cardiac settings. “The integration of Caption AI with the Vscan Air SL handheld ultrasound opens an entirely new chapter for cardiac screening. This technology empowers users with guidance and tools for high quality ultrasound scans and supports earlier detection of cardiac disease,” said Roland Rott, president and CEO, Ultrasound, GE HealthCare. “The strategic acquisition of Caption Health in 2023 continues to expand the capabilities of our products and solidifies our leadership in ultrasound and the emerging artificial intelligence landscape.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare price target raised to $110 from $80 at Argus
- GE Healthcare (NASDAQ:GEHC) Gets Boost from New Technology
- GE Hlthcare Tech Inc put volume heavy and directionally bearish
- GE HealthCare announces FDA clearance for nCommand Lite technology
- GE HealthCare accelerates AI innovation with models powered by Nvidia